TY - JOUR
T1 - Differential coupling of μ-, δ-, and κ-opioid receptors to Gα16- mediated stimulation of phospholipase C
AU - Lee, Jonathan W.M.
AU - Joshi, Sushma
AU - Chan, Joy S.C.
AU - Wong, Yung H.
PY - 1998/5
Y1 - 1998/5
N2 - The μ-opioid receptor has recently been shown to stimulate phosphoinositide-specific phospholipase C via the pertussis toxin-sensitive G16 protein. Given the promiscuous nature of G16 and the high degree of resemblance of signaling properties of the three opioid receptors, both δ- and κ-opioid receptors are likely to activate G16. Interactions of δ- and κ-opioid receptors with G16 were examined by coexpressing the opioid receptors and Gα16 in COS-7 cells. The δ-selective agonist [D-Pen2,D- Pen5] enkephalin potently stimulated the formation of inositol phosphates in cells coexpressing the δ-opioid receptor and Gα16. The δ-opioid receptor-mediated stimulation of phospholipase C was absolutely dependent on the coexpression of Gα16 and exhibited appropriate ligand selectivity and dose dependency. Similar transfection studies revealed only weak stimulation by the μ-opioid receptor, whereas the κ-opioid receptor produced moderate phospholipase C activity. Gα16 thus appeared to interact differentially with the three opioid receptors. Radioligand binding assays indicate that the μ-opioid receptor was expressed at a ewer level than those of the δ-and κ- opioid receptors. To examine if differential coupling to Gα16 is prevalent, a panel of G(s)- or G(l)-coupled receptors was coexpressed with Gα16 in COS-7 cells and assayed for agonist-induced stimulation of phospholipase C. Activation of α2- and β2-adrenergic, dopamine D1 and D2, adenosine A1, somatostatin-1 and -2, C5a, formyl peptide, and luteinizing hormone receptors all resulted in stimulation of phospholipase C, with maximal stimulations ranging from 1.5- to almost 17-fold. These findings suggest that the promiscuous Gα16 can in fact discriminate among different receptors and that such preferential interaction might in part be due to the abundance of receptors.
AB - The μ-opioid receptor has recently been shown to stimulate phosphoinositide-specific phospholipase C via the pertussis toxin-sensitive G16 protein. Given the promiscuous nature of G16 and the high degree of resemblance of signaling properties of the three opioid receptors, both δ- and κ-opioid receptors are likely to activate G16. Interactions of δ- and κ-opioid receptors with G16 were examined by coexpressing the opioid receptors and Gα16 in COS-7 cells. The δ-selective agonist [D-Pen2,D- Pen5] enkephalin potently stimulated the formation of inositol phosphates in cells coexpressing the δ-opioid receptor and Gα16. The δ-opioid receptor-mediated stimulation of phospholipase C was absolutely dependent on the coexpression of Gα16 and exhibited appropriate ligand selectivity and dose dependency. Similar transfection studies revealed only weak stimulation by the μ-opioid receptor, whereas the κ-opioid receptor produced moderate phospholipase C activity. Gα16 thus appeared to interact differentially with the three opioid receptors. Radioligand binding assays indicate that the μ-opioid receptor was expressed at a ewer level than those of the δ-and κ- opioid receptors. To examine if differential coupling to Gα16 is prevalent, a panel of G(s)- or G(l)-coupled receptors was coexpressed with Gα16 in COS-7 cells and assayed for agonist-induced stimulation of phospholipase C. Activation of α2- and β2-adrenergic, dopamine D1 and D2, adenosine A1, somatostatin-1 and -2, C5a, formyl peptide, and luteinizing hormone receptors all resulted in stimulation of phospholipase C, with maximal stimulations ranging from 1.5- to almost 17-fold. These findings suggest that the promiscuous Gα16 can in fact discriminate among different receptors and that such preferential interaction might in part be due to the abundance of receptors.
KW - G proteins
KW - Opioid receptor
KW - Phospholipase C
KW - Signal transduction
UR - https://openalex.org/W2048733671
UR - https://www.scopus.com/pages/publications/0031969805
U2 - 10.1046/j.1471-4159.1998.70052203.x
DO - 10.1046/j.1471-4159.1998.70052203.x
M3 - Journal Article
C2 - 9572309
SN - 0022-3042
VL - 70
SP - 2203
EP - 2211
JO - Journal of Neurochemistry
JF - Journal of Neurochemistry
IS - 5
ER -